Brief: HBC Publishes Clinical Trial, Calls It Paradigm-Changing

Hofseth Biocare ASA

14/04/2026 10:10

April 14 (Reuters) - Hofseth Biocare ASA HBC.OL:

ANNOUNCES PUBLICATION OF HEAD-TO-HEAD CLINICAL TRIAL RESULTS FOR OMEGO

OMEGO INCREASES OMEGA 3 INDEX BY OVER 70% AFTER 14 WEEKS VERSUS COMPARATOR

OMEGO MORE EFFECTIVE AT REDUCING INFLAMMATORY MARKERS HSCRP, TNFA, AND IL-6

CLINICAL STUDY CHALLENGES ASSUMPTION THAT HIGHER-DOSE FISH OILS DELIVER GREATER BENEFITS

Source text: ID:nGNE198xZK

Further company coverage: HBC.OL

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))